[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

September 2017 - July 1883

Decade

Year

Issue

November 15, 2016, Vol 316, No. 19, Pages 1945-2056

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2016;316(19):1945-1947. doi:10.1001/jama.2015.14588
Viewpoint

Cholesterol, Cardiovascular Risk, Statins, PCSK9 Inhibitors, and the Future of LDL-C Lowering

Abstract Full Text
JAMA. 2016;316(19):1967-1968. doi:10.1001/jama.2016.16575

This Viewpoint discusses the role of implementation and translational science and digital platforms for improving population cardiovascular risk and advancing precision treatments in an era of intensive statin therapy and PCSK9 inhibitors.

What to Believe and Do About Statin-Associated Adverse Effects

Abstract Full Text
JAMA. 2016;316(19):1969-1970. doi:10.1001/jama.2016.16557

This Viewpoint reviews the myths about and makes recommendations for statin treatment.

Statins for Primary Prevention in Older AdultsUncertainty and the Need for More Evidence

Abstract Full Text
JAMA. 2016;316(19):1971-1972. doi:10.1001/jama.2016.15212

This Viewpoint summarizes the findings and limitations of clinical trial evidence regarding the benefits and risks of statins for primary prevention of atherosclerotic cardiovascular disease in persons older than 75 years.

Expanding Payment Reform in MedicareThe Cardiology Episode-Based Payment Model

Abstract Full Text
JAMA. 2016;316(19):1973-1974. doi:10.1001/jama.2016.16146

This Viewpoint discusses a cardiology episode-based payment model proposed by the Centers for Medicare & Medicaid Services to improve the quality and efficiency of cardiac care.

A Piece of My Mind

Hailey

Abstract Full Text
JAMA. 2016;316(19):1975-1976. doi:10.1001/jama.2016.10251
Editorial

Interpretation and Use of Another Statin Guideline

Abstract Full Text
JAMA. 2016;316(19):1977-1979. doi:10.1001/jama.2016.15087

Statins for Primary PreventionThe Debate Is Intense, but the Data Are Weak

Abstract Full Text
JAMA. 2016;316(19):1979-1981. doi:10.1001/jama.2016.15085

Evolving Approaches for Statins in Primary PreventionProgress, but Questions Remain

Abstract Full Text
JAMA. 2016;316(19):1981-1983. doi:10.1001/jama.2016.15094

AABB Red Blood Cell Transfusion GuidelinesSomething for Almost Everyone

Abstract Full Text
JAMA. 2016;316(19):1984-1985. doi:10.1001/jama.2016.10887
Original Investigation

Effect of Conscious Sedation vs General Anesthesia on Early Neurological Improvement Among Patients With Ischemic Stroke Undergoing Endovascular ThrombectomyA Randomized Clinical Trial

Abstract Full Text
free access
JAMA. 2016;316(19):1986-1996. doi:10.1001/jama.2016.16623

This randomized clinical trial comparing use of general anesthesia vs conscious sedation among patients with acute ischemic stroke in the anterior circulation undergoing thrombectomy, reports no significant difference in improvement of neurological status at 24-hour follow-up.

US Preventive Services Task Force

Recommendation Statement

Statin Use for the Primary Prevention of Cardiovascular Disease in AdultsUS Preventive Services Task Force Recommendation Statement

Abstract Full Text
free access has active quiz has multimedia
JAMA. 2016;316(19):1997-2007. doi:10.1001/jama.2016.15450

This Recommendation Statement from the US Preventive Services Task Force recommends use of low- to moderate-dose statins for primary prevention in adults aged 40 to 75 years who have 1 or more CVD risk factors and a calculated CVD event risk of 10% or greater (B recommendation).

Evidence Report

Statins for Prevention of Cardiovascular Disease in AdultsEvidence Report and Systematic Review for the US Preventive Services Task Force

Abstract Full Text
free access has active quiz
JAMA. 2016;316(19):2008-2024. doi:10.1001/jama.2015.15629

This Evidence Report and systematic review to support the 2016 US Preventive Services Task Force Recommendation Statement on use of statins for prevention of cardiovascular disease (CVD) summarizes published trial evidence about the benefits and harms of statins for primary CVD prevention.

Special Communication

Clinical Practice Guidelines From the AABBRed Blood Cell Transfusion Thresholds and Storage

Abstract Full Text
has active quiz
JAMA. 2016;316(19):2025-2035. doi:10.1001/jama.2016.9185

This study summarizes transfusion recommendations from the AABB (formerly known as the American Association of Blood Banks) based on randomized clinical trials.

From The JAMA Network

Infant Eating Behaviors and Risk for Overweight

Abstract Full Text
JAMA. 2016;316(19):2036-2037. doi:10.1001/jama.2016.16899

This commentary discusses a randomized clinical trial published in JAMA Pediatrics that examined associations between responsive parenting and infant weight gain between birth and 28 weeks and overweight status.

JAMA Clinical Guidelines Synopsis

Transfusion of Red Blood Cells

Abstract Full Text
JAMA. 2016;316(19):2038-2039. doi:10.1001/jama.2016.12870

This JAMA Clinical Guidelines Synopsis summarizes the UK National Clinical Guideline Centre’s 2015 guideline on transfusion of red blood cells.

Research Letter

Temporal Changes in the Association Between Modifiable Risk Factors and Coronary Heart Disease Incidence

Abstract Full Text
free access
JAMA. 2016;316(19):2041-2043. doi:10.1001/jama.2016.13614

This study uses data from 5 National Heart, Lung, and Blood Institute cohorts to investigate changes in association between modifiable risk factors and coronary heart disease from 1983-1995 and from 1996-2011.

Changes in Characteristics and Time to Recognition of Medical Scientists Awarded a Nobel Prize

Abstract Full Text
free access
JAMA. 2016;316(19):2043-2044. doi:10.1001/jama.2016.15702

This study describes the changes in characteristics of winners of the Noble Prize in Physiology or Medicine over time as well as their time to recognition.

Comment & Response

HIV Transmission During Condomless Sex With a Seropositive Partner With Suppressed Infection

Abstract Full Text
JAMA. 2016;316(19):2044-2045. doi:10.1001/jama.2016.16030

Therapy for Cellulitis

Abstract Full Text
JAMA. 2016;316(19):2045-2046. doi:10.1001/jama.2016.15604

HIV Transmission During Condomless Sex With a Seropositive Partner With Suppressed Infection—Reply

Abstract Full Text
JAMA. 2016;316(19):2045. doi:10.1001/jama.2016.16033

Therapy for Cellulitis

Abstract Full Text
JAMA. 2016;316(19):2046-2047. doi:10.1001/jama.2016.15607

Therapy for Cellulitis

Abstract Full Text
JAMA. 2016;316(19):2046. doi:10.1001/jama.2016.15610

Therapy for Cellulitis

Abstract Full Text
JAMA. 2016;316(19):2047. doi:10.1001/jama.2016.15613
Correction

Error in Abstract

Abstract Full Text
free access
JAMA. 2016;316(19):2047-2048. doi:10.1001/jama.2016.16337

Error in Figure Legends

Abstract Full Text
free access
JAMA. 2016;316(19):2048. doi:10.1001/jama.2016.16194

Incorrect Information

Abstract Full Text
free access
JAMA. 2016;316(19):2048. doi:10.1001/jama.2016.16820
Medical News & Perspectives

A Precision Medicine Approach to Clinical Trials

Abstract Full Text
JAMA. 2016;316(19):1953-1955. doi:10.1001/jama.2016.12137

This Medical News feature discusses the advances in clinical trial design and implementation that have grown out of the precision medicine approach.

Global Health

Where Will Zika Spread?

Abstract Full Text
JAMA. 2016;316(19):1956. doi:10.1001/jama.2016.16151

UN Leaders Commit to Fight Antimicrobial Resistance

Abstract Full Text
JAMA. 2016;316(19):1956. doi:10.1001/jama.2016.16531

Growing Numbers of Refugees Worldwide Are Children

Abstract Full Text
JAMA. 2016;316(19):1956. doi:10.1001/jama.2016.16533
News From the Food and Drug Administration

“Artificial Pancreas” Is Approved

Abstract Full Text
JAMA. 2016;316(19):1957. doi:10.1001/jama.2016.16344

Safe Relief for Teething Symptoms

Abstract Full Text
JAMA. 2016;316(19):1957. doi:10.1001/jama.2016.16350

HCV Drug Warning

Abstract Full Text
JAMA. 2016;316(19):1957. doi:10.1001/jama.2016.16352
Poetry and Medicine

Reprieve

Abstract Full Text
JAMA. 2016;316(19):2049. doi:10.1001/jama.2016.10040
JAMA Revisited

Monomachy With Cholesterol

Abstract Full Text
JAMA. 2016;316(19):2050. doi:10.1001/jama.2015.17110
JAMA Patient Page

Lipid Disorders: Screening and Treatment

Abstract Full Text
free access
JAMA. 2016;316(19):2056. doi:10.1001/jama.2016.16650
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2016;316(19):1949-1950. doi:10.1001/jama.2015.14589
×